Advertisement
Screener

OTC:PVCT | Conversion of Stock, Amount Converted | PROVECTUS BIOPHARMACEUTICALS, INC.

0.8 / 5 stars · 19/120 Roast Me

PROVECTUS BIOPHARMACEUTICALS, INC. Conversion of Stock, Amount Converted

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:ConversionOfStockAmountConverted1 · last filed 2019-03-07

  • PROVECTUS BIOPHARMACEUTICALS, INC. conversion of stock, amount converted for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
  • PROVECTUS BIOPHARMACEUTICALS, INC. conversion of stock, amount converted for the quarter ending 2017-09-30 was $0.00.
  • PROVECTUS BIOPHARMACEUTICALS, INC. conversion of stock, amount converted for the quarter ending 2017-06-30 was -$1.59K.
  • PROVECTUS BIOPHARMACEUTICALS, INC. conversion of stock, amount converted for the quarter ending 2017-03-31 was $5.58K.
  • PROVECTUS BIOPHARMACEUTICALS, INC. conversion of stock, amount converted for fiscal 2017 was $3.99K, a 97.38% decline from fiscal 2016.
  • PROVECTUS BIOPHARMACEUTICALS, INC. conversion of stock, amount converted for fiscal 2016 was $151.94K.
Period endConversion of Stock, Amount Converted 3 monthConversion of Stock, Amount Converted 6 monthConversion of Stock, Amount Converted 9 monthConversion of Stock, Amount Converted 12 month
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
$0.00
derived: sum of 2 quarters · filed 2019-03-07
-$1.59K
derived: sum of 3 quarters · filed 2019-03-07
$3.99K
10-K · filed 2019-03-07
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$1.59K
derived: sum of 2 quarters · filed 2018-11-08
$3.99K
10-Q · filed 2018-11-08
$124.86K
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30-$1.59K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$3.99K
10-Q · filed 2018-08-07
$124.86K
derived: sum of 3 quarters · filed 2018-08-07
2017-03-31$5.58K
10-Q · filed 2018-05-09
$126.46K
derived: sum of 2 quarters · filed 2018-05-09
2016-12-31$120.88K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23
$151.94K
10-K · filed 2018-03-23
2016-09-30$31.07K
10-Q · filed 2017-11-08